QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient

Cardiac MRI Findings Suggest Myocarditis in Severe Ebola Virus Disease

(2017) Daniel S. Chertow et al.   JACC-Cardiovascular Imaging

Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)—Sierra Leone, 2014

(2016) Chang-Qing Bai et al.   CLINICAL INFECTIOUS DISEASES

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

(2016) Daouda Sissoko et al.   PLOS MEDICINE

Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States*

(2015) Viranuj Sueblinvong et al.   CRITICAL CARE MEDICINE

Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adults

(2015) Yuji Kumagai et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Necrotizing Scleritis, Conjunctivitis, and Other Pathologic Findings in the Left Eye and Brain of an Ebola Virus–Infected Rhesus Macaque (Macaca mulatta) With Apparent Recovery and a Delayed Time of Death

(2015) Derron A. Alves et al.   JOURNAL OF INFECTIOUS DISEASES

Favipiravir—a prophylactic treatment for Ebola contacts?

(2015) Michel Van Herp et al.   LANCET

Dose regimen of favipiravir for Ebola virus disease

(2015) France Mentré et al.   LANCET INFECTIOUS DISEASES

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

(2014) Lisa Oestereich et al.   ANTIVIRAL RESEARCH

Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses

(2014) Roosecelis Brasil Martines et al.   JOURNAL OF PATHOLOGY

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

(2013) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

A Case Series of Proton Pump Inhibitor–Induced Hypomagnesemia

(2010) Ewout J. Hoorn et al.   AMERICAN JOURNAL OF KIDNEY DISEASES